SynthesisNaunyn-Schmiedeberg's archives of pharmacology2025

Unraveling the rationale and conducting a comprehensive assessment of AdipoRon (adiponectin receptor agonist) as a candidate drug for diabetic nephropathy and cardiomyopathy prevention and intervention-a systematic review.

Lucas Fornari Laurindo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.